SCHEMBL26423462

SCHEMBL26423462

c1cnc2nc3oc4ccncc4c3nc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.38
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 5/20 0.36
HSD17B10 Q99714 3/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HPGD P15428 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
IDO1 P14902 1/20 0.32
BCHE P06276 2/20 0.31
ACHE P22303 2/20 0.31
F2 P00734 2/20 0.31
NCOA1 Q15788 1/20 0.31
FGFR1 P11362 1/20 0.31
FLT1 P17948 1/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26423470 0.94 MAPK14 (0.38) MAPK14ALDH1A1KDM4EHSD17B10MEN1
SCHEMBL26423464 0.90 MAPK14 (0.37) MAPK14ALDH1A1KDM4EHSD17B10MEN1
SCHEMBL26423458 0.84 MAPK14 (0.37) MAPK14ALDH1A1KDM4EHSD17B10MEN1
SCHEMBL26423372 0.83 ALDH1A1 (0.38) ALDH1A1KDM4EHSD17B10MEN1KMT2A
SCHEMBL26423457 0.78 KDM4E (0.39) MAPK14ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL26423469 0.78 KDM4E (0.39) MAPK14ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL26423473 0.76 DAGLA (0.32) ALDH1A1KDM4ENCOA1F7F3
SCHEMBL26423471 0.76 DAGLA (0.32) ALDH1A1KDM4ENCOA1F7F3
SCHEMBL26423483 0.75 MAPK10 (0.30)
SCHEMBL11884996 0.73 KDM4E (0.54) ALDH1A1KDM4EHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 MAPK14 1074/4885ALDH1A1 302/4885KDM4E 2800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.